B. Gary

发表

Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors.

A. Abadi, Tamer M. Ibrahim, K. Abouzid, 2009, Bioorganic & medicinal chemistry.

Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach.

A. Abadi, J. Lehmann, H. Tinsley, 2010, European journal of medicinal chemistry.

Design and Synthesis of Substituted Pyridazinone‐1‐Acetylhydrazones as Novel Phosphodiesterase 4 Inhibitors

H. Tinsley, B. Gary, G. Piazza, 2016, Archiv der Pharmazie.

Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives.

M. Negri, A. Abadi, H. Tinsley, 2012, European journal of medicinal chemistry.

Design, Synthesis and Structure–Activity Relationship of Functionalized Tetrahydro‐β‐carboline Derivatives as Novel PDE5 Inhibitors

A. Abadi, B. Gary, G. Piazza, 2011, Archiv der Pharmazie.

Colon Tumor Cell Growth–Inhibitory Activity of Sulindac Sulfide and Other Nonsteroidal Anti-Inflammatory Drugs Is Associated with Phosphodiesterase 5 Inhibition

H. Tinsley, B. Gary, G. Piazza, 2010, Cancer Prevention Research.

A Novel Sulindac Derivative That Does Not Inhibit Cyclooxygenases but Potently Inhibits Colon Tumor Cell Growth and Induces Apoptosis with Antitumor Activity

H. Tinsley, B. Gary, G. Piazza, 2009, Cancer Prevention Research.

Rese Col Sulf Is A

B. Gary, G. Piazza, Yonghe Li, 2010 .

Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention

B. Gary, G. Piazza, A. Keeton, 2014, Medicinal Chemistry Research.

Design of Novel β‐Carboline Derivatives with Pendant 5‐Bromothienyl and Their Evaluation as Phosphodiesterase‐5 Inhibitors

R. Hartmann, A. Abadi, B. Gary, 2013, Archiv der Pharmazie.

Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach.

A. Abadi, J. Lehmann, H. Tinsley, 2010, European journal of medicinal chemistry.

Novel Quinazolin‐4(3H)‐one/Schiff Base Hybrids as Antiproliferative and Phosphodiesterase 4 Inhibitors: Design, Synthesis, and Docking Studies

B. Gary, G. Piazza, Joshua C. Canzoneri, 2014, Archiv der Pharmazie.

Synthesis and molecular modeling of novel tetrahydro-β-carboline derivatives with phosphodiesterase 5 inhibitory and anticancer properties.

A. Abadi, H. Tinsley, B. Gary, 2011, Journal of medicinal chemistry.

Synthesis, molecular modeling and biological evaluation of novel tadalafil analogues as phosphodiesterase 5 and colon tumor cell growth inhibitors, new stereochemical perspective.

A. Abadi, H. Tinsley, B. Gary, 2010, European journal of medicinal chemistry.

Synthesis of some dihydropyrimidine-based compounds bearing pyrazoline moiety and evaluation of their antiproliferative activity.

B. Gary, G. Piazza, A. Keeton, 2013, European journal of medicinal chemistry.

Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G

Wei Zhang, A. Abadi, H. Tinsley, 2009, Molecular Cancer Therapeutics.

An Efficient and Green One-Pot Synthesis of Novel Spirooxindole Derivatives with Potential Anti-tumor Activity in an Aqueous Solvent

A. Abadi, B. Gary, G. Piazza, 2014 .

Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity

X. Chen, B. Gary, G. Piazza, 2014, Oncogene.

Synthesis of novel tadalafil analogues and their evaluation as phosphodiesterase inhibitors and anticancer agents.

A. Abadi, H. Tinsley, B. Gary, 2009, Arzneimittel-Forschung.

Synthesis, molecular modeling and biological evaluation of novel tadalafil analogues as phosphodiesterase 5 and colon tumor cell growth inhibitors, new stereochemical perspective.

A. Abadi, H. Tinsley, B. Gary, 2010, European journal of medicinal chemistry.

Sulindac Selectively Inhibits Colon Tumor Cell Growth by Activating the cGMP/PKG Pathway to Suppress Wnt/β-Catenin Signaling

Xi Chen, Bing Zhu, Heather N. Tinsley, 2013, Molecular Cancer Therapeutics.

A Novel Sulindac Derivative that Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and β-Catenin Transcriptional Activity

Xi Chen, Wei Zhang, A. Abadi, 2012, Cancer Prevention Research.

Inhibition of PDE5 by Sulindac Sulfide Selectively Induces Apoptosis and Attenuates Oncogenic Wnt/β-Catenin–Mediated Transcription in Human Breast Tumor Cells

H. Tinsley, B. Gary, G. Piazza, 2011, Cancer Prevention Research.

Interaction of Nkx3.1 and p27kip1 in prostate tumor initiation.

B. Gary, S. Abdulkadir, I. Eltoum, 2004, The American journal of pathology.

Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats

X. Chen, H. Tinsley, B. Gary, 2023, Cancers.

Sulindac inhibits tumor cell invasion by suppressing NF-κB mediated transcription of microRNAs

Q. Cui, B. Gary, G. Piazza, 2012, Oncogene.

Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10

X. Chen, Wei Zhang, B. Gary, 2015, Oncotarget.

A Novel Sulindac Derivative Lacking Cyclooxygenase-Inhibitory Activities Suppresses Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate Model

B. Gary, G. Piazza, J. Lü, 2010, Cancer Prevention Research.

NSAIDs: Old Drugs Reveal New Anticancer Targets

H. Tinsley, B. Gary, G. Piazza, 2010, Pharmaceuticals.

Panepoxydone Targets NF-kB and FOXM1 to Inhibit Proliferation, Induce Apoptosis and Reverse Epithelial to Mesenchymal Transition in Breast Cancer

B. Gary, G. Piazza, Y. Xi, 2014, PloS one.

Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion

B. Gary, G. Piazza, L. Sklar, 2015, Journal of biomedical research.

Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.

B. Gary, H. Weiss, U. Manne, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Overexpression of the oncogenic kinase Pim-1 leads to genomic instability.

B. Gary, S. Abdulkadir, A. Kraft, 2003, Cancer research.

Abstract 331: Beta-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG

Ashley S. Lindsey, B. Gary, G. Piazza, 2016 .

A novel access to arylated and heteroarylated beta-carboline based PDE5 inhibitors.

A. Abadi, H. Tinsley, B. Gary, 2010, Medicinal chemistry (Shariqah (United Arab Emirates)).

Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53.

R. Hartmann, A. Abadi, B. Gary, 2013, Bioorganic & medicinal chemistry.

β-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG

Ashley S. Lindsey, B. Gary, G. Piazza, 2015, Oncotarget.